Statins as potential therapeutic drug for asthma?

Respiratory Research

Volumn 13, Issue , 2012, Pages

  Yuan, Cheng ^a   Zhou, Lin ^a   Cheng, Jiyun ^a   Zhang, Jingying ^a   Teng, Yue ^a   Huang, Mao ^a   Adcock, Ian M ^b   Barnes, Peter J ^b   Yao, Xin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Anti inflammatory; Asthma; Lung function; Statins

Indexed keywords

ATORVASTATIN; SIMVASTATIN; ANTIASTHMATIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ASTHMA; COCHRANE LIBRARY; DRUG EFFICACY; EMBASE; EMERGENCY WARD; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MEDLINE; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; ANIMAL; EVIDENCE BASED MEDICINE; META ANALYSIS; MORTALITY; PREVALENCE; RISK FACTOR; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; EVIDENCE-BASED MEDICINE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PREVALENCE; QUALITY OF LIFE; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84869884061     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-13-108     Document Type: Review

References (46)

1. Riccioni G. Antileukotriene drugs: clinical application, effectiveness and safety. Curr Med Chem 2007, 14(18):1966-1977. 10.2174/092986707781368522, 17691939.
2. Strunk RC. Omalizumab for Asthma. N Engl J Med 2006, 354(25):2689-2695. 10.1056/NEJMct055184, 16790701.
3. Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med 2009, 15(1):39-45. 10.1097/MCP.0b013e32831da894, 19077704.
4. Peters-Golden M, Swern A, Bird SS, et al. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006, 27:495-503. 10.1183/09031936.06.00077205, 16507848.
5. Farah CS, Kermode JA, Downie SR, Brown NJ, Hardaker KM, Berend N, King GG, Salome CM. Obesity Is a Determinant of Asthma Control 2011, Chest: Independent of Inflammation and Lung Mechanics.
6. Prescott G, Woodruff BM. T-helper Type 2-driven Inflammation Defines Major Subphenotypes of Asthma. Am J Respir Crit Care Med 2009, 180:388-395. 10.1164/rccm.200903-0392OC, 2742757, 19483109.
7. Zeki AA, Kenyon NJ, Goldkorn T. Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further research. Drug Metab Lett 2011, 5(1):40-44. 10.2174/187231211794455217, 21198438.
8. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990, 343(6257):425-430. 10.1038/343425a0, 1967820.
9. Kume H. RhoA/Rho-kinase as a therapeutic target in asthma. Curr Med Chem 2008, 15(27):2876-2885. 10.2174/092986708786242831, 18991642.
10. Chiba Y, Matsusue K, Misawa M. RhoA, a possible target for treatment of airway hyperresponsiveness in bronchial asthma. J Pharmacol Sci 2010, 114(3):239-247. 10.1254/jphs.10R03CR, 20948164.
11. McKay A, Leung BP, McInnes IB, Thomson NC, Liew FY. A Novel Anti-Inflammatory Role of Simvastatin in a Murine Model of Allergic Asthma. J Immunol 2004, 172(5):2903-2908.
12. Takeda N, Kondo M, Ito S, Ito Y, Shimokata K, Kume H. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin. AmJ Respir Cell Mol Biol 2006, 35(6):722-729.
13. Stanek EJ, Aubert RE, Xia F, Frueh FW, Sanders C, Weiss ST, Epstein RS. Impact of statin therapy on asthma-related event costs in adult asthma patients. Value Health 2009, 12(3):A121-A122.
14. Feschenko Y, Lashyna L, Kramarskaya N, Polianska M, Matvienko J. Clinical and functional effectiveness of atorvastatin in complex therapy of severe bronchial asthma [Abstract]. European Respiratory Society Annual Congress, Berlin, Germany, October 4-8 2009, [E4554]..
15. Maneechotesuwan K, Ekjiratrakul W, Kasetsinsombat K, Wongkajornsilp A, Barnes PJ. Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase. J Allergy Clin Immunol 2010, 126:754-762. e751., 10.1016/j.jaci.2010.08.005, 20920765.
16. Braganza G, Chaudhuri R, McSharry C, Weir CJ, Donnelly I, Jolly L, Lafferty J, Lloyd SM, Spears M, Mair F, et al. Effects of short-term treatment with atorvastatin in smokers with asthma-a randomized controlled trial. BMC Pulm Med 2011, 11:16. 10.1186/1471-2466-11-16, 3087704, 21473764.
17. Christiansen SC, Schatz M, Eddleston J, Wagelie-Steffen A, Yang SJ, Chen W, Zuraw BL. HMG-CoA reductase inhibitors and asthma severity. J Allergy ClinImmunol 2009, 123(2):S84.
18. Ostroukhova M, Kouides RW, Friedman E. The effect of statin therapy on allergic patients with asthma. Ann Allergy Asthma Immunol 2009, 103(6):463-468. 10.1016/S1081-1206(10)60261-X, 20084838.
19. Foumani S, Nejatifar F, Forghan Parast K, Heidarinejad S, Mortazhejri G. Effects of atorvastatin in asthmatic patients under treatment with high dose inhaled or oral steroid [Abstract]. European Respiratory Society Annual Congress, Barcelona, Spain, September 18-22 2010, [372]..
20. Jadad AR. Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?. Controlled Clin Trials 1996, 17:1-12. 10.1016/0197-2456(95)00134-4, 8721797.
21. Menzies D, Nair A, Meldrum KT, Fleming D, Barnes M, Lipworth BJ. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. J Allergy Clin Immunol 2007, 119:328-335. 10.1016/j.jaci.2006.10.014, 17141851.
22. Hothersall EJ, Chaudhuri R, McSharry C, Donnelly I, Lafferty J, McMahon AD, Weir CJ, Meiklejohn J, Sattar N, McInnes I, et al. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax 2008, 63:1070-1075. 10.1136/thx.2008.100198, 18757458.
23. Fahimi F, Jamaati H, Taheri ZM, Fakharian A, Salamzadeh J. Does atorvastatin have effect on lung function and morbidity as add on therapy in asthmatic patients? [Abstract]. Eur Respir J 2007, 490s:2960.
24. Moini A, Azimi G, Farivar A. Evaluation of atorvastatin for the treatment of patients with asthma: a double-blind randomized clinical trial. Allergy Asthma Immunol Res 2012, 4(5):290-294. 10.4168/aair.2012.4.5.290, 3423603, 22950035.
25. Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Simvastatin in the treatment of asthma: lack of steroid-sparing effect. Thorax 2010, 65:891-896. 10.1136/thx.2010.138990, 20861293.
26. Pagovich O, Wang E, Lee-Wong M. Statins may improve asthma. J Allergy Clin Immunol 2010, 125(2):AB45.
27. Adams R, Appleton S, Wilson D, Ruffin R. Effects of lipid lowering therapy in a representative asthma population. Respirology 2010, 15:A46.
28. Moskovljevic J, Zivkovic M. Effect on lung function and morbidity in asthmatic patients who use atorvastatin. Allergy: Eur J Allergy Clin Immunol 2010, 65:526.
29. Al Obaidi AHA, Al Samarai AGM. Evaluation anti-inflammatory and anti-oxidant activity of simvastatin in asthma. J Bahrain Med Soc 2008, 20(2):55-59.
30. Huang CC, Chan WL, Chen YC, Chen TJ, Chou KT, Lin SJ, Chen JW, Leu HB. Statin use in patients with asthma - a nationwide population-based study. Eur J Clin Invest 2011, 41(5):507-512. 10.1111/j.1365-2362.2010.02434.x, 21128938.
31. Lokhandwala T, West-Strum D, Banahan BF, Bentley JP, Yang Y. Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysis. BMJ Open 2012, 2(3).
32. Enright PL, Newman AB. Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group 1999, 116:603-613.
33. Parameswaran K. Asthma in the elderly: underperceived, underdiagnosed and undertreated; a community survey. Respir Med 1998, 92:573-577. 10.1016/S0954-6111(98)90311-0, 9692125.
34. Hartert TV. Underutilization of controller and rescue medications among older adults with asthma requiring hospital care. J Am Geriatr Soc 2000, 48:651-657.
35. Alexeeff SE. Statin Use Reduces Decline in Lung Function: VA Normative Aging Study. Am J Respir Crit Care Med 2007, 176:742-747. 10.1164/rccm.200705-656OC, 2020828, 17673694.
36. Keddissi JI. The Use of Statins and Lung Function in Current and Former Smokers. Chest 2007, 132(6):1764-1771. 10.1378/chest.07-0298, 17908708.
37. Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007, 101:2240-2247. 10.1016/j.rmed.2007.06.031, 17686624.
38. Lavoie KL, Bacon SL, Labrecque M, et al. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med 2006, 100:648-657. 10.1016/j.rmed.2005.08.001, 16159709.
39. Forno E, Lescher R. Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol 2011, 127(3):741-749. 10.1016/j.jaci.2010.12.010, 3056233, 21377042.
40. Rolfe BE, Worth NF. Rho and vascular disease. Atherosclerosis 2005, 183(1):1-16. 10.1016/j.atherosclerosis.2005.04.023, 15982657.
41. Neese RA, Misell LM, Turner S, Chu A, Kim J, Cesar D, et al. Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Nat Acad Sci USA 2002, 99(24):15345-15350. 10.1073/pnas.232551499, 137719, 12424339.
42. Chu A, Ordonez ET, Hellerstein MK. Measurement of mouse vascular smooth muscle and atheroma cell proliferation by 2H2O incorporation into DNA. Am J Physiol Cell Physiol 2006, 291(5):C1014-C1021. 10.1152/ajpcell.00191.2006, 16774990.
43. Knapp AC, Huang J, Starling G. Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death. Atherosclerosis 2000, 152:217-227. 10.1016/S0021-9150(99)00462-1, 10996358.
44. Hilgendorff A, Muth H, Parviz B. Statins differ in their ability to block NFkB activation in human blood monocytes. Int J Clin Pharmacol Ther 2003, 41:397-401.
45. Kiener PA, Davis PM, Murray JL. Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors. Int Immunopharmacol 2001, 1:105-118. 10.1016/S0162-3109(00)00272-1, 11367508.
46. Amir A, Zeki JMB. Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling?. Transl Res 2010, 156:335-349. 10.1016/j.trsl.2010.09.003, 2990975, 21078495.